Ligand binding and cytochemical analysis of estrogen and progesterone receptors in relation to follow-up in patients with breast cancer

Annals of the New York Academy of Sciences

Volumn 963, Issue , 2002, Pages 98-103

  Castagnetta, L ^a,b   Traina, A ^a   Agostara, B ^a   Miele, M ^a   Campisi, I ^a   Calabro M ^a   Marasa L ^a   Carruba, G ^b  

^a Ospedale Oncologico M Ascoli   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Breast cancer; Cytochemical analysis; Estrogen receptors; Ligand binding; Progesterone receptors

Indexed keywords

ESTROGEN RECEPTOR; GROWTH FACTOR; LIGAND; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ASSAY; BREAST CANCER; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOCHEMISTRY; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; ONCOGENE NEU; PREDICTION; PROGNOSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0036295413     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04100.x     Document Type: Conference Paper

References (11)

1. Steroid hormones, receptor, and antagonist
2. The prognosis of the breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes
3. Quantitative image analysis of estrogen and progesterone receptor as prognostic tool for selection of breast cancer patients
4. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
5. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: The need for quality assurance
6. Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: Constitutive expression of the human EGF gene
7. Do multiple ER assays give significant additional information for the management of breast cancer?
8. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls
9. Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer
10. Recent postmenopause but non ER status identifies a subset of primary breast cancer patients with an higher risk of relapse